Pepaxto 20 mg lyophilized powder for injection Images
Generic Name: melphalan flufenamide
This medication has been identified as Pepaxto 20 mg lyophilized powder for injection. It is supplied by Oncopeptides Inc.
Pepaxto is used in the treatment of Multiple Myeloma and belongs to the drug class alkylating agents. Pepaxto 20 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Pepaxto
- Generic Name
- melphalan flufenamide
- Strength
- 20 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oncopeptides Inc.
- National Drug Code (NDC)
- 73657-0020 (Discontinued)
See also:
More about Pepaxto (melphalan flufenamide)
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.